Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation

Oncogene

Volumn 32, Issue 26, 2013, Pages 3119-3129

  Gopisetty, G ^a   Xu, J ^a   Sampath, D ^a   Colman, H ^a,b   Puduvalli, V K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

CD133; epigenetic regulation; glioma Stem Cell; Myc; promoter methylation; Sp1

Indexed keywords

CD133 ANTIGEN; MEMBRANE PROTEIN; METHYL CPG BINDING PROTEIN 2; MITHRAMYCIN; MYC PROTEIN; NUCLEIC ACID BINDING PROTEIN; OLIGONUCLEOTIDE; PROTEIN MBD1; PROTEIN PROM1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENETIC REGULATION; GLIOMA CELL; INHIBITION KINETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STEM CELL; TRANSCRIPTION INITIATION SITE;

ANTIGENS, CD; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GLIOMA; GLYCOPROTEINS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; NEOPLASTIC STEM CELLS; NUCLEIC ACID SYNTHESIS INHIBITORS; ONCOGENE PROTEIN P55(V-MYC); PEPTIDES; PLICAMYCIN; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84879689573     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.331     Document Type: Article

References (50)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature [Review] 2001; 414: 105-111.
2. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
3. Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, Watt SM et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000; 275: 5512-5520.
4. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT et al. A novel fivetransmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-5021.
5. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000; 97: 14720-14725.
6. Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvillispecific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA. 1997; 94: 12425-12430.
7. Shmelkov SV, St Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005; 37: 715-719.
8. Neuzil J, Stantic M, Zobalova R, Chladova J, Wang X, Prochazka L et al. Tumourinitiating cells vs cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun 2007; 355: 855-859.
9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
10. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ et al. CD133(p) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007; 67: 4010-4015.
11. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010; 17: 362-375.
12. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14: 123-129.
13. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al. Analysis of gene expression and chemoresistance of CD133p cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
14. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760.
15. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S et al. Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 2008; 18: 1037-1046.
16. Yi JM, Tsai HC, Glockner SC, Lin S, Ohm JE, Easwaran H et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 2008; 68: 8094-8103.
17. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 2004; 103: 2055-2061.
18. Marsden CG, Wright MJ, Pochampally R, Rowan BG. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. Methods Mol Biol 2009; 590: 363-375.
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
20. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
21. Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoek M et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Research 2010; 70: 719-729.
22. Elsaba TM, Martinez-Pomares L, Robins AR, Crook S, Seth R, Jackson D et al. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 2010; 5: 10714.
23. Briggs MR, Kadonaga JT, Bell SP, Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 1986; 234: 47-52.
24. Kadonaga JT, Courey AJ, Ladika J, Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 1988; 242: 1566-1570.
25. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 1987; 51: 1079-1090.
26. Cheng L, Jin Z, Liu L, Yan Y, Li T, Zhu X et al. Characterization and promoter analysis of the mouse nestin gene. FEBS Lett 2004; 565: 195-202.
27. Wu DY, Yao Z. Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. Cell Res 2006; 16: 319-322.
28. Ray BK, Ray A. Sp1-mediated transactivation of the rabbit alpha 1 acid glycoprotein- encoding gene involves a cis-acting element in the 5'-proximal promoter region. Gene 1994; 147: 253-258.
29. Lopez-Rodriguez C, Chen HM, Tenen DG, Corbi AL. Identification of Sp1-binding sites in the CD11c (p150,95 alpha) and CD11a (LFA-1 alpha) integrin subunit promoters and their involvement in the tissue-specific expression of CD11c. Eur J Immunol 1995; 25: 3496-3503.
30. Chen HM, Pahl HL, Scheibe RJ, Zhang DE, Tenen DG. The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J Biol Chem 1993; 268: 8230-8239.
31. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6: 635-645.
32. Cowling VH, Cole MD. Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 2006; 16: 242-252.
33. Parisi F, Wirapati P, Naef F. Identifying synergistic regulation involving c-Myc and sp1 in human tissues. Nucleic Acids Res 2007; 35: 1098-1107.
34. Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE et al. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 2008; 3: 3769.
35. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008; 455: 1129-1133.
36. Bednarik DP, Duckett C, Kim SU, Perez VL, Griffis K, Guenthner PC et al. DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs. New Biol 1991; 3: 969-976.
37. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 1990; 18: 3975-3982.
38. Mancini DN, Singh SM, Archer TK, Rodenhiser DI. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 1999; 18: 4108-4119.
39. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W et al. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998; 16: 1161-1169.
40. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumorsuppressor gene. Oncogene 1993; 8: 1063-1067.
41. Zutter MM, Ryan EE, Painter AD. Binding of phosphorylated Sp1 protein to tandem Sp1 binding sites regulates alpha2 integrin gene core promoter activity. Blood 1997; 90: 678-689.
42. Dynan WS, Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 1983; 35: 79-87.
43. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 2000; 28: 669-677.
44. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992; 69: 905-914.
45. Boyes J, Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 1992; 11: 327-333.
46. Boyes J, Bird A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 1991; 64: 1123-1134.
47. Clouaire T, de Las Heras JI, Merusi C, Stancheva I. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res 2010; 38: 4620-4634.
48. Ng HH, Jeppesen P, Bird A. Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol 2000; 20: 1394-1406.
49. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18: 6538-6547.
50. Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007; 99: 1410-1414.